Twelve Points Wealth Management’s Pfizer PFE Stock Holding History

Twelve Points Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$238K	Sell	9,868 -698	-7%	-$18.3K	0.05%	188
2026 Q1	$297K	Buy	10,566 +32	+0.3%	+$852	0.07%	162
2025 Q4	$268K	Sell	10,534 -4,830	-31%	-$122K	0.06%	166
2025 Q3	$391K	Sell	15,364 -42	-0.3%	-$1.04K	0.1%	140
2025 Q2	$373K	Buy	15,406 +279	+2%	+$6.51K	0.1%	143
2025 Q1	$383K	Sell	15,127 -7	-0%	-$183	0.1%	132
2024 Q4	$402K	Sell	15,134 -157	-1%	-$4.26K	0.12%	132
2024 Q3	$443K	Buy	15,291 +202	+1%	+$5.89K	0.14%	130
2024 Q2	$422K	Buy	+15,089	New	+$415K	0.15%	128
2023 Q2	–	Sell	-5,319	Closed	-$217K	–	167
2023 Q1	$217K	Buy	5,319 +354	+7%	+$15.3K	0.12%	151
2022 Q4	$254K	Hold	4,965	–	–	0.17%	142
2022 Q3	$217K	Hold	4,965	–	–	0.17%	146
2022 Q2	$260K	Sell	4,965 -233	-4%	-$11.9K	0.2%	144
2022 Q1	$269K	Sell	5,198 -1,418	-21%	-$73.6K	0.2%	147
2021 Q4	$391K	Buy	+6,616	New	+$328K	0.32%	111

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Twelve Points Wealth Management's PFE Position: Q2 2026 in Review

Twelve Points Wealth Management reduced its Pfizer (PFE) stake by 6.6% in Q2 2026, selling an estimated $18.3K and leaving 9,868 shares worth $238K. The position accounts for 0.05% of the portfolio, ranked #188.

Twelve Points Wealth Management first reported a position in PFE in Q4 2021 and has held it in 15 quarters since. The position peaked at $443K in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Twelve Points Wealth Management held 9,868 shares of Pfizer worth $238K as of Q2 2026.
Twelve Points Wealth Management sold 698 Pfizer shares in Q2 2026, an estimated $18.3K.
Pfizer made up 0.05% of Twelve Points Wealth Management's portfolio in Q2 2026, its #188 holding.
Twelve Points Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 15 quarters since.
Twelve Points Wealth Management's Pfizer position peaked at $443K in Q3 2024.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Twelve Points Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.